Curcumin suppresses tumor necrosis factor-α-induced matrix metalloproteinase-2 expression and activity in rat vascular smooth muscle cells via the NF-κB pathway

Experimental and Therapeutic Medicine

Volumn 7, Issue 6, 2014, Pages 1653-1658

  Zhong, Yi ^a   Yu, Wenyan ^b   Feng, Jian ^a   Fan, Zhongcai ^a   Li, Jiafu ^a  

^a THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Curcumin; Matrix metalloproteinase 2; Nuclear factor B; Tumor necrosis factor

Indexed keywords

CURCUMIN; GELATINASE A; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR PROTEIN; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL MIGRATION ASSAY; CELL VIABILITY ASSAY; COLORIMETRY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; MALE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 84898438684     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1647     Document Type: Article

References (28)

1. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
2. Augé N, Maupas-Schwalm F, Elbaz M, Thiers JC, Waysbort A, Itohara S, Krell HW, Salvayre R and Nègre-Salvayre A: Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 110: 571-578, 2004.
3. Aoyagi M, Yamamoto M, Azuma H, Nagashima G, Niimi Y, Tamaki M, Hirakawa K and Yamamoto K: Immunolocalization of matrix metalloproteinases in rabbit carotid arteries after balloon denudation. Histochem Cell Biol 109: 97-102, 1998.
4. Newby AC and Zaltsman AB: Fibrous cap formation or destruction the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc Res 41: 345-360, 1999.
5. Caird J, Napoli C, Taggart C, Farrell M and Bouchier-Hayes D: Matrix metalloproteinases 2 and 9 in human atherosclerotic and non-atherosclerotic cerebral aneurysms. Eur J Neurol 13: 1098-1105, 2006.
6. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN and Kuttan R: Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94: 79-83, 1995.
7. Surh YJ: Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem Toxicol 40: 1091-1097, 2002.
8. Goel A, Kunnumakkara AB and Aggarwal BB: Curcumin as 'Curecumin': from kitchen to clinic. Biochem Pharmacol 75: 787-809, 2008.
9. Kamimura M, Bea F, Akizawa T, Katus HA, Kreuzer J and Viedt C: Platelet-derived growth factor induces tissue factor expression in vascular smooth muscle cells via activation of Egr-1. Hypertension 44: 944-951, 2004.
10. Chang W, Lim S, Song H, Song BW, Kim HJ, Cha MJ, Sung JM, Kim TW and Hwang KC: Cordycepin inhibits vascular smooth muscle cell proliferation. Eur J Pharmacol 597: 64-69, 2008.
11. Yu YM and Lin HC: Curcumin prevents human aortic smooth muscle cells migration by inhibiting of MMP-9 expression. Nutr Metab Cardiovasc Dis 20: 125-132, 2010.
12. Schwartz SM, Heimark RL and Majesky MW: Developmental mechanisms underlying pathology of arteries. Physiol Rev 70: 1177-1209, 1990.
13. Owens GK: Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75: 487-517, 1995.
14. Lijnen HR: Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 86: 324-333, 2001.
15. Sheu MJ, Lin HY, Yang YH, Chou CJ, Chien YC, Wu TS and Wu CH: Demethoxycurcumin, a major active curcuminoid from Curcuma longa, suppresses balloon injury induced vascular smooth muscle cell migration and neointima formation: An in vitro and in vivo study. Mol Nutr Food Res 57: 1586-1597, 2013.
16. Baeuerle PA and Baltimore D: I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242: 540-546, 1988.
17. Baud V and Karin M: Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11: 372-377, 2001.
18. Barnes PJ and Karin M: Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997.
19. Lee B and Moon SK: Resveratrol inhibits TNF-alpha-induced proliferation and matrix metalloproteinase expression in human vascular smooth muscle cells. J Nutr 135: 2767-2773, 2005.
20. McKellar GE, McCarey DW, Sattar N and McInnes IB: Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 6: 410-417, 2009.
21. Newby AC: Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol 28: 2108-2114, 2008.
22. Hayden MS and Ghosh S: Signaling to NF-kappaB. Genes Dev 18: 2195-2224, 2004.
23. Kim HS, Kim HJ, Park KG, Kim YN, Kwon TK, Park JY, Lee KU, Kim JG and Lee IK: Alpha-lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-kappaB transcriptional activity. Exp Mol Med 39: 106-113, 2007.
24. Kim CH and Moon SK: Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells. Arch Biochem Biophys 435: 264-272, 2005.
25. Gloire G, Legrand-Poels S and Piette J: NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72: 1493-1505, 2006.
26. Schreck R, Rieber P and Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
27. Janssen-Heininger YM, Poynter ME and Baeuerle PA: Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med 28: 1317-1327, 2000.
28. Bar-Shai M, Carmeli E, Ljubuncic P and Reznick AZ: Exercise and immobilization in aging animals: the involvement of oxidative stress and NF-kappaB activation. Free Radic Biol Med 44: 202-214, 2008.